Zydus Lifesciences has introduced VaxiFlu-4, India's first quadrivalent influenza vaccine to combat flu season. This new vaccine provides broader protection by covering both influenza A and B ...

The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...

Zydus Lifesciences on Wednesday said it is introducing a vaccine for protection against new strain of influenza virus. The company is introducing country's first flu protection quadrivalent ...

Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...

Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus ...

Zydus Lifesciences Limited announced on Tuesday that it has secured the final approval from the United States Food and Drug Administration (USFDA) for manufacturing and marketing apalutamide ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...

Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and ...